Capital Growth Management’s Tenet Healthcare THC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$17.3M Sell
335,000
-190,000
-36% -$11.3M 2.27% 19
2022
Q2
$27.6M Buy
525,000
+65,000
+14% +$4.52M 3.28% 10
2022
Q1
$39.5M Sell
460,000
-20,000
-4% -$1.64M 3.65% 4
2021
Q4
$39.2M Buy
+480,000
New +$35.1M 3.6% 4
2021
Q2
– Sell
-680,000
Closed -$35.4M – 83
2021
Q1
$35.4M Buy
+680,000
New +$34.4M 3.23% 3
2014
Q4
– Sell
-1,965,000
Closed -$117M – 74
2014
Q3
$117M Buy
+1,965,000
New +$110M 3.29% 8

Other funds holding THC

Capital Growth Management's THC Position: Q3 2022 in Review

Capital Growth Management reduced its Tenet Healthcare (THC) stake by 36% in Q3 2022, selling an estimated $11.3M and leaving 335,000 shares worth $17.3M. The position accounts for 2.27% of the portfolio, ranked #19.

Capital Growth Management first reported a position in THC in Q3 2014 and has held it in 6 quarters since. The position peaked at $117M in Q3 2014. 360 funds tracked by Wall St. Rank hold THC as of Q3 2022.

  • Capital Growth Management held 335,000 shares of Tenet Healthcare worth $17.3M as of Q3 2022.
  • Capital Growth Management sold 190,000 Tenet Healthcare shares in Q3 2022, an estimated $11.3M.
  • Tenet Healthcare made up 2.27% of Capital Growth Management's portfolio in Q3 2022, its #19 holding.
  • Capital Growth Management first reported a position in Tenet Healthcare in Q3 2014 and has held it in 6 quarters since.
  • Capital Growth Management's Tenet Healthcare position peaked at $117M in Q3 2014.
  • 360 funds tracked by Wall St. Rank held Tenet Healthcare as of Q3 2022.

Based on Capital Growth Management's 13F filing for Q3 2022, filed 14 Nov 2022.